Effect of standard‐dose and high‐dose pimobendan on select indices of renal and cardiac function in dogs with American College of Veterinary Internal Medicine stage B2 myxomatous mitral valve disease
Abstract Background Pimobendan might have favorable effects on renal function but this has not been well‐studied in dogs with myxomatous mitral valve disease (MMVD). Objectives Determine the effects of standard‐dose (SD_pimo) and high‐dose pimobendan (HD_pimo) on glomerular filtration rate (GFR) and...
Main Authors: | Joanna L. Kaplan, Lance C. Visser, Catherine T. Gunther‐Harrington, Eric S. Ontiveros, Luke A. Wittenburg, Carrie A. Palm, Joshua A. Stern |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-11-01
|
Series: | Journal of Veterinary Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1111/jvim.16537 |
Similar Items
-
Pharmacokinetics of pimobendan after oral administration to dogs with myxomatous mitral valve disease
by: Anna K. McManamey, et al.
Published: (2023-11-01) -
Gastric pH and serum gastrin concentration in age‐matched healthy dogs and dogs with chronic kidney disease
by: Kylie Grady, et al.
Published: (2023-11-01) -
Pharmacokinetics of Repeated Oral Dosing with Coenzyme Q10 in Cavalier King Charles Spaniels with Myxomatous Mitral Valve Disease
by: Liselotte B. Christiansen, et al.
Published: (2020-09-01) -
Retrospective evaluation of 22 dogs with leptospirosis treated with extracorporeal renal replacement therapies (2018‐2021)
by: Antonia Da Fonseca Ioannou, et al.
Published: (2024-03-01) -
Indicators for pulmonary hypertension in dogs with degenerative mitral valve disease
by: Pasika Chalermpromma, et al.
Published: (2023-12-01)